We dont have much data yet, but one study from late in 2025, which compared tirzepatide to both transdermal (through the skin) testosterone and placebo, made an argument worth considering: Authors La Vignera & colleagues argued that tirzepatide may be effective in improving both metabolic parameters, ED, and gonadal hormone levels in patients with obesity and metabolic hypogonadism, also known as low testosterone levels
Slowing an infusion may help some rate-related symptomsbut does not diagnose them Chest symptoms, low blood pressure, breathing difficulty, severe pain, or neurologic symptoms require assessment rather than automatic continuation at a slower rate
Interestingly, the closest relatives of many mtDNA-modifying enzymes, such as mtDNA polymerase, are bacteriophage proteins [94], suggesting that an infection of the mitochondrial ancestor contributed to the development of mtDNA maintenance machinery
Both are highly effective when paired with consistent use